Standing David - Department of Molecular and Integrative Physiology, University of Kansas Medical Center

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

DCLK1-mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma

Levi Arnold, Marrion Yap, Nathan Farrokhian, Laura Jackson,Michael Barry,Thuc Ly, Pachiappan Arjunan, Angela Kaczorowski-Worthley, Carter Tews, Avisha Pandey,Austin Morrison,Michael P. Washburn,David Standing, Juan P. Gomez,Nanda Kumar Yellapu,David Johnson,Linheng Li,Shahid Umar,Shrikant Anant,Sufi Mary Thomas

Molecular Cancerno. 1 (2025): 1-24

引用0浏览0WOS引用

DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma

Levi Arnold, Marion Yap, Laura Jackson,Michael Barry,Thuc Ly,Austin Morrison, Juan P Gomez,Michael P Washburn,David Standing,Nanda Kumar Yellapu,Linheng Li,Shahid Umar,Shrikant Anant,Sufi Mary Thomas

bioRxiv the preprint server for biology (2024)

引用0浏览0WOS引用

Selective Targeting of IRAK1 Attenuates Low Molecular Weight Hyaluronic Acid-Induced Stemness and Non-Canonical STAT3 Activation in Epithelial Ovarian Cancer

David Standing,Prasad Dandawate,Sumedha Gunewardena,Obdulia Covarrubias-Zambrano,Katherine F. Roby,Dineo Khabele,Andrea Jewell,Ossama Tawfik,Stefan H. Bossmann,Andrew K. Godwin,Scott J. Weir,Roy A. Jensen,Shrikant Anant

Cell Death and Disease（2024）

引用0浏览0WOSNATURE引用

Bypassing the Tollway; a Novel Path to TLR4 Independent Stemness Regulation

David Standing, Shrikant Anant

Cancer Letters (2024): 216545

引用0浏览0引用

Cancer letters 581 (2024) 216528 216545 bypassing the tollway; a novel path to tlr4 independent stemness regulation

David Standing,Shrikant Anant

CANCER LETTERS (2024)

引用0浏览0引用

Role of STAT3 in Pancreatic Cancer

Zachary Hamel, Sierra Sanchez,David Standing,Shrikant Anant

Exploration of Targeted Anti-tumor Therapyno. 1 (2024): 20-33

引用0浏览0WOS引用

Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone Targeting Cellular JUN Proto-Oncogene, AP-1 Transcription Factor Subunit Inhibits Head and Neck Squamous Cell Carcinoma Progression

Levi Arnold, Juan Pineda Gomez,Michael Barry, Marrion Yap, Laura Jackson,Thuc Ly,David Standing,Subhash B Padhye,Bernhard Biersack,Shrikant Anant,Sufi Mary Thomas

Exploration of Targeted Anti-tumor Therapypp.1104-1121, (2023)

引用0浏览0WOS引用

The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy

David Standing,Emma Feess,Satvik Kodiyalam, Michael Kuehn,Zachary Hamel, Jaimie Johnson,Sufi Mary Thomas,Shrikant Anant

CANCERS（2023）

引用1浏览0WOS引用

566 PROLACTIN SIGNALING INDUCES GLUTAMINE METABOLISM IN PANCREATIC CANCER

David Standing,Prasad Dandawate,Michael A. Kuehn,Sumedha Gunewardena,Shrikant Anant

GASTROENTEROLOGYno. 6 (2023): S100-S100

引用0浏览0引用

IRAK1 is a Critical Mediator of Low Molecular Weight Hyaluronic Acid-Induced Stemness in High-Grade Serous Ovarian Cancer

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn